A study was to investigate the tolerability of EVT 301 in young and elderly volunteers.
Latest Information Update: 21 Jan 2020
At a glance
- Drugs EVT 301 (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions
- Sponsors Evotec SE
- 15 Sep 2006 New trial record.